REAL WORLD USE OF IXAZOMIB WITH LENALIDOMIDE AND DEXAMETHASONE FOR PATIENTS WITH RELAPSED AND RELAPSED REFRACTORY MULTIPLE MYELOMA

被引：0
|
作者：
Ziff, M. [1 ]
Cheesman, S. [1 ]
Kyriakou, C. [1 ]
Mehta, A. [1 ]
Papanikolaou, X. [1 ]
Rabin, N. [1 ]
Wechalekar, A. [1 ]
Yong, K. [1 ]
Popat, R. [1 ]
机构：
[1] Univ Coll London Hosp NHS Fdn Trust, London, England
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1975
引用
收藏
页码：786 / 787
页数：2
相关论文
共 50 条
  • [21] Network meta-analysis of efficacy of ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma
    DerSarkissian, Maral
    Cranmer, Holly
    Dabora, Jonathan
    Bocharova, Iryna
    Cherepanov, Dasha
    Cheng, Mu
    Bhak, Rachel H.
    Duh, Mei Sheng
    HEMATOLOGY, 2023, 28 (01)
  • [22] Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma
    Dabkara, Deepak
    Bajpai, Jyoti
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2008, 29 (03) : 10 - 13
  • [23] Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma
    Hajek, Roman
    Minarik, Jiri
    Straub, Jan
    Pour, Ludek
    Jungova, Alexandra
    Berdeja, Jesus G.
    Boccadoro, Mario
    Brozova, Lucie
    Spencer, Andrew
    Rhee, Frits van
    Vela-Ojeda, Jorge
    Thompson, Michael A.
    Abonour, Rafat
    Chari, Ajai
    Cook, Gordon
    Costello, Caitlin L.
    Davies, Faith E.
    Hungria, Vania T. M.
    Lee, Hans C.
    Leleu, Xavier
    Puig, Noemi
    Rifkin, Robert M.
    Terpos, Evangelos
    Usmani, Saad Z.
    Weisel, Katja C.
    Zonder, Jeffrey A.
    Barinova, Magda
    Kuhn, Matyas
    Silar, Jiri
    Capkova, Lenka
    Galvez, Kenny
    Lu, Jin
    Elliott, Jennifer
    Stull, Dawn Marie
    Ren, Kaili
    Maisnar, Vladimir
    FUTURE ONCOLOGY, 2021, 17 (19) : 2499 - 2512
  • [24] Quality of life and response to treatment with ixazomib-lenalidomide-dexamethasone (IRd) in patients with relapsed/refractory multiple myeloma (RRMM) in a real-world setting
    Ionova, T.
    Anchukova, L.
    Dubov, S.
    Esenina, T.
    Ivanova, L.
    Kaplanov, K.
    Kochkareva, Y.
    Kopylova, A.
    Kravchuk, T.
    Levanov, A.
    Li, O.
    Nikitina, T. P.
    Rukavitsyn, O.
    Saraeva, N.
    Savinova, M.
    Shelekhova, T.
    Simashova, P.
    Shirokova, M.
    Vinogradova, O.
    Volkova, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S655 - S655
  • [25] CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN JAPANESE PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Ri, M.
    Suzuki, K.
    Chou, T.
    Sugiura, I.
    Takezako, N.
    Sunami, K.
    Ishida, T.
    Izumi, T.
    Ozaki, S.
    Iida, S.
    HAEMATOLOGICA, 2016, 101 : 787 - 788
  • [26] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma
    Nikhil C Munshi
    Constantine Mitsiades
    Paul G Richardson
    Kenneth C Anderson
    Nature Clinical Practice Oncology, 2008, 5 : 374 - 375
  • [27] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
    Siegel, D. S.
    Richardson, P.
    Dimopoulos, M.
    Moreau, P.
    Mitsiades, C.
    Weber, D.
    Houp, J.
    Gause, C.
    Vuocolo, S.
    Eid, J.
    Graef, T.
    Anderson, K. C.
    BLOOD CANCER JOURNAL, 2014, 4 : e182 - e182
  • [28] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
    D S Siegel
    P Richardson
    M Dimopoulos
    P Moreau
    C Mitsiades
    D Weber
    J Houp
    C Gause
    S Vuocolo
    J Eid
    T Graef
    K C Anderson
    Blood Cancer Journal, 2014, 4 : e182 - e182
  • [29] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma
    Munshi, Nikhil C.
    Mitsiades, Constantine
    Richardson, Paul G.
    Anderson, Kenneth C.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (07): : 374 - 375
  • [30] Real-world evidence of Carfilzomib, Lenalidomide and Dexamethasone (KRD) Scheme in patients with relapsed / refractory multiple myeloma
    Garcia-Guinon, Antoni
    Charry, Paola Andrea
    Jimenez, Maria
    Sarra, Josep
    Delgado, Izarbe
    de la Torre, Laura Segura
    Santaliestra, Marta
    Garcia-Pintos, Marta
    Gonzalez, Yolanda
    Senin, Alicia
    Motllo, Cristina
    Abella, Eugenia
    Cabezudo, Elena
    Granell, Miquel
    Sancho, Esther
    Herranz, Maria Jose
    Seres, Yasmina
    Gironella, Mercedes
    Soler, Juan Alfons
    Marti-Tutusaus, Josep Maria
    Ben Azaiz, Ran
    de Larrea, Carlos Fernandez
    ANNALS OF HEMATOLOGY, 2025, 104 (02) : 1177 - 1186
12345